Literature DB >> 28544686

Regulatory T cells and CTLA-4 in idiopathic nephrotic syndrome.

Shoji Tsuji1, Takahisa Kimata1, Sohsaku Yamanouchi1, Tetsuya Kitao1, Jiro Kino1, Chikushi Suruda1, Kazunari Kaneko1.   

Abstract

The pathogenesis of idiopathic nephrotic syndrome (INS) remains unknown. Recently, it was postulated that suppression of regulatory T cells (Treg) leads to massive proteinuria in INS, although there is some controversy. Considering the important role of cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) in Treg-mediated immune suppression, the aim of this study was therefore to clarify the involvement of Treg and CTLA-4 in the pathogenesis of INS. Fifteen patients with INS were enrolled. Their blood was sampled twice, once at onset and once at remission induced by glucocorticoid. Although median Treg number was significantly lower at onset than in healthy children, it increased at remission. Similarly, serum CTLA-4 concentration significantly increased at remission compared with onset. Furthermore, a positive significant correlation was observed between Treg number and serum CTLA-4 level. This suggests that Treg and CTLA-4 are involved in the induction of remission in INS.
© 2017 Japan Pediatric Society.

Entities:  

Keywords:  CD80; cytotoxic T-lymphocyte-associated protein 4; idiopathic nephrotic syndrome; podocyte; regulatory T cell

Mesh:

Substances:

Year:  2017        PMID: 28544686     DOI: 10.1111/ped.13255

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  8 in total

Review 1.  Immunopathogenesis of idiopathic nephrotic syndrome in children: two sides of the coin.

Authors:  Jing Chen; Xiao-Hui Qiao; Jian-Hua Mao
Journal:  World J Pediatr       Date:  2021-03-03       Impact factor: 2.764

Review 2.  Podocytopathies.

Authors:  Jeffrey B Kopp; Hans-Joachim Anders; Katalin Susztak; Manuel A Podestà; Giuseppe Remuzzi; Friedhelm Hildebrandt; Paola Romagnani
Journal:  Nat Rev Dis Primers       Date:  2020-08-13       Impact factor: 52.329

3.  Clinical Significance of Probiotics for Children with Idiopathic Nephrotic Syndrome.

Authors:  Tadashi Yamaguchi; Shoji Tsuji; Shohei Akagawa; Yuko Akagawa; Jiro Kino; Sohsaku Yamanouchi; Takahisa Kimata; Masaki Hashiyada; Atsushi Akane; Kazunari Kaneko
Journal:  Nutrients       Date:  2021-01-26       Impact factor: 5.717

4.  Compositional alterations of gut microbiota in children with primary nephrotic syndrome after initial therapy.

Authors:  Yulin Kang; Dan Feng; Helen Ka-Wai Law; Wei Qu; Ying Wu; Guang-Hua Zhu; Wen-Yan Huang
Journal:  BMC Nephrol       Date:  2019-11-26       Impact factor: 2.388

Review 5.  Autoimmunity in Focal Segmental Glomerulosclerosis: A Long-Standing Yet Elusive Association.

Authors:  Manuel Alfredo Podestà; Claudio Ponticelli
Journal:  Front Med (Lausanne)       Date:  2020-11-20

Review 6.  New Insights into the Treatment of Glomerular Diseases: When Mechanisms Become Vivid.

Authors:  Da-Wei Lin; Cheng-Chih Chang; Yung-Chien Hsu; Chun-Liang Lin
Journal:  Int J Mol Sci       Date:  2022-03-24       Impact factor: 5.923

7.  Non-lupus full-house nephropathy-immune dysregulation as a rare cause of pediatric nephrotic syndrome: Answers.

Authors:  Orsolya Horváth; György S Reusz; Veronika Goda; Kata Kelen; István Balogh; Magdolna Kardos; Krisztián Kállay; Áron Cseh; Attila J Szabó; Gergely Kriván
Journal:  Pediatr Nephrol       Date:  2021-12-17       Impact factor: 3.714

8.  Hemizygous nonsense variant in the moesin gene (MSN) leads to a new autoimmune phenotype of Immunodeficiency 50.

Authors:  András L Kovács; Judit Kárteszi; Zoltán Prohászka; Tibor Kalmár; Gábor Késmárky; Katalin Koltai; Zsuzsanna Nagy; Judit Sebők; Tibor Vas; Krisztián Molnár; Tímea Berki; Katalin Böröcz; Csaba Gyömörei; József Szalma; Miklós Egyed; Szabina Horváth; Péter Oláh; Dorottya Csuka; Viktória Németh; Rolland Gyulai
Journal:  Front Immunol       Date:  2022-09-01       Impact factor: 8.786

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.